Latest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
IVC filters: The genie's out of the bottle
Posted Feb 03, 2012
at 08:30 AM, EDT
by Samuel Goldhaber
The placement of inferior vena cava (IVC) filters has grown exponentially in the US, with up to 20% of these being placed in inappropriate patients. As we balance the benefit vs risk for this procedure and evaluate cost, Dr Paul Stein's proposed randomized trial will help us to see more clearly.
See also:
Stein PD, Matta F, Huss RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med 2011; 124:655-661. Abstract.
Previous posts
Should we prescribe novel anticoagulants or warfarin as first line agents for stroke prevention in AF?
4 Comments |
Posted May 06, 2012
at 01:25 PM, EDT by Samuel
at 01:25 PM, EDT by Samuel
Recent PE thrombolysis trials: MAPPET, MOPETT, and MUPPET, with Dr Stavros Konstantinides
No comments |
Posted Apr 27, 2012
at 11:55 AM, EDT by Samuel
at 11:55 AM, EDT by Samuel
The US Postal Service promotes heart health
No comments |
Posted Apr 20, 2012
at 01:50 PM, EDT by Samuel
at 01:50 PM, EDT by Samuel
Thrombolysis in acute pulmonary embolism: An update with Dr Stavros Konstantinides
No comments |
Posted Apr 04, 2012
at 03:08 PM, EDT by Samuel
at 03:08 PM, EDT by Samuel
Einstein PE: Rivaroxaban shines as viable monotherapy for pulmonary embolism
1 Comments |
Posted Mar 26, 2012
at 10:25 AM, EDT by Samuel
at 10:25 AM, EDT by Samuel
Also from theheart.org
Blogs I read
Who's Talking
Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA















Comments